Topic Hub

Ethnicity ZEPBOUND

5 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.

5articles

38keywords mapped

2026-05-27latest review

Explore

Ethnicity ZEPBOUND library

Showing 5 of 5 clinical reviews.

Dosing & Monitoring2026-05-27

Zepbound (Tirzepatide) Dose Adjustments for Hispanic and Latino Patients

Evidence-based guide to Zepbound (tirzepatide) dosing considerations for Hispanic and Latino patients, covering pharmacogenomic factors, clinical trial subgroup data, and practical titration guidance.

Read clinical review

Safety2026-05-27

Zepbound (Tirzepatide) Safety Profile Differences in East Asian Patients

Evidence-based review of how Zepbound (tirzepatide) safety, tolerability, dosing, and pharmacokinetics differ in East Asian populations, including SURMOUNT and SURPASS-J trial data.

Read clinical review

Safety2025-01-28

Zepbound Hispanic / Latino Safety Profile Differences: What the Evidence Shows

A clinician-reviewed deep dive into tirzepatide (Zepbound) safety, efficacy, and pharmacogenomic considerations specific to Hispanic and Latino patients, with ethnicity-stratified trial data and dosing guidance.

Read clinical review

Questions2025-07-10

Zepbound in Black and African Ancestry Patients: Documented Efficacy Gaps and What They Mean Clinically

A detailed review of tirzepatide (Zepbound) efficacy data stratified by Black and African ancestry, including SURMOUNT-1 subgroup analysis, pharmacogenomic context, hypertension considerations, and practical dosing guidance.

Read clinical review

Clinical Reviews2026-05-27

Zepbound in Hispanic and Latino Patients: Documented Efficacy Differences

Evidence-based review of how Zepbound (tirzepatide) performs in Hispanic and Latino populations, including SURMOUNT trial subgroup data, pharmacogenomic considerations, and dosing guidance.

Read clinical review